Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ann & Robert H Lurie Children's Hospital of Chicago
Aim 1: Identify the needs, desires, concerns, and expectations of AYA patients with SCD and their parents/caregivers that will guide implementation of a mHealth tool, HU-Go, designed to improve adherence to HU. We will conduct semi-structured interviews with patients and their parents/caregivers. Transcripts will be independently coded and thematic analysis will be conducted.
Hypothesis 1: AYA patients with SCD and their parents/caregivers will identify specific features, content, and usability requirements of HU-Go.
Aim 2: Assess the longitudinal relationship of HU adherence to HRQoL domains, including fatigue and depression. HU adherence will be measured using electronic pill bottles, self-report measures, laboratory markers, and medication possession ratio (MPR). HRQOL will be assessed using PROMIS® measures.
Hypothesis 2: Low HU adherence is associated with impairment of HRQoL domains.
Aim 3: Conduct a single-arm, pilot study to determine the effect size associated with improvement in HU adherence after using HU-Go for 12 weeks. Adherence will be measured using self-report measures, laboratory markers and MPR.
Hypothesis 3: HU-Go will improve HU adherence by at least 20%.
Age
12–25
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
At least 12 years old at the time of study enrollment
Diagnosis of sickle cell disease (hemoglobin SS or SC or S/B 0 thalassemia) confirmed by hemoglobin electrophoresis
On hydroxyurea
Own or have access to a smartphone
Be able to speak and read English
You may not be if
Chronic monthly transfusion support
Any hemoglobinopathy other than sickle cell disease